Mechanistic and biophysical characterization of polymyxin resistance response regulator PmrA in Acinetobacter baumannii

Mechanistic and biophysical characterization of polymyxin resistance response regulator PmrA in Acinetobacter baumannii

IntroductionAcinetobacter baumannii PmrAB is a crucial two-component regulatory system (TCS) that plays a vital role in conferring resistance to polymyxin. PmrA, a response regulator belonging to the OmpR/PhoB family, is composed of a C-terminal DNA-binding effector domain and an N-terminal receiver...

Full description

Bibliographic Details
Main Authors:	Zhenlin Ouyang, Wenbo He, Min Jiao, Qinyue Yu, Yucheng Guo, Moath Refat, Qian Qin, Jiaxin Zhang, Qindong Shi, Fang Zheng, Yurong Wen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Microbiology
Subjects:	polymyxin resistance response regulator Acinetobacter baumannii PmrA mechanism
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1293990/full

Similar Items

The Characterization of Two-Component System PmrA/PmrB in Cronobacter sakazakii
by: Jingjing Hua, et al.
Published: (2020-06-01)

Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance
by: Yan Zhu, et al.
Published: (2020-08-01)

Emergence of polymyxin B-resistant Acinetobacter baumannii in hospitals in Rio de Janeiro
by: Gabrielle L. Genteluci, et al.

<i>Acinetobacter baumannii</i> under Acidic Conditions Induces Colistin Resistance through PmrAB Activation and Lipid A Modification
by: Seo-Yeon Ko, et al.
Published: (2023-04-01)

Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against Acinetobacter baumannii
by: Shixing Zhu, et al.
Published: (2023-06-01)

Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii
by: Shixing Zhu, et al.
Published: (2022-09-01)

PKPD Modeling of the Inoculum Effect of Acinetobacter baumannii on Polymyxin B in vivo
by: Alexia Chauzy, et al.
Published: (2022-03-01)

Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates
by: Saranya Vijayakumar, et al.
Published: (2024-02-01)

Strategies for Rapid Identification of Acinetobacter baumannii Membrane Proteins and Polymyxin B’s Effects
by: Yun Lu, et al.
Published: (2021-09-01)

Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
by: Cheng Lyu, et al.
Published: (2020-04-01)

Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2024-01-01)

Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report
by: Wei Guo, et al.
Published: (2018-02-01)

In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran
by: Shahin najar peerayeh, et al.
Published: (2014-03-01)

Effects of amikacin, polymyxin-B, and sulbactam combination on the pharmacodynamic indices of mutant selection against multi-drug resistant Acinetobacter baumannii
by: Shixing Zhu, et al.
Published: (2022-10-01)

The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant Acinetobacter baumannii
by: Jiayuan Zhang, et al.
Published: (2022-11-01)

Testing stand of PMR analyzer for measuring viscosity and composition of multicomponent liquids by PMR relaxometry method
by: Nguyen Chi Kien, et al.
Published: (2020-05-01)

Acinetobacter baumannii: an evolving and cunning opponent
by: Jingchao Shi, et al.
Published: (2024-01-01)

Comparison of in vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrug-resistant Acinetobacter baumannii isolates
by: Yuan Wang, et al.
Published: (2024-04-01)

A novel decoy strategy for polymyxin resistance in Acinetobacter baumannii
by: Jaeeun Park, et al.
Published: (2021-06-01)

Intrathecal Injection of Tigecycline and Polymyxin B in the Treatment of Extensively Drug-Resistant Intracranial Acinetobacter baumannii Infection: A Case Report and Review of the Literature
by: Li Z, et al.
Published: (2022-03-01)

Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons
by: Mai M. Zafer, et al.
Published: (2023-08-01)

In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
by: Zhang H, et al.
Published: (2021-11-01)

Synergistic antibacterial effect of ultrasound microbubbles combined with chitosan-modified polymyxin B-loaded liposomes on biofilm-producing Acinetobacter baumannii
by: Fu Y, et al.
Published: (2019-03-01)

Metabolic Responses to Polymyxin Treatment in <italic toggle="yes">Acinetobacter baumannii</italic> ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling
by: Yan Zhu, et al.
Published: (2019-02-01)

In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii [Corrigendum]
by: Zhang H, et al.
Published: (2021-12-01)

Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii
by: Go Kamoshida, et al.
Published: (2022-10-01)

Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand
by: Ngamprasertchai T, et al.
Published: (2018-08-01)

Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report
by: Haiyan Xing, et al.
Published: (2021-07-01)

Synergistic Inhibitory Effect of Polymyxin B in Combination with Ceftazidime against Robust Biofilm Formed by Acinetobacter baumannii with Genetic Deficiency in AbaI/AbaR Quorum Sensing
by: Yinyue Li, et al.
Published: (2022-02-01)

Comparative genomics of two ST 195 carbapenem-resistant Acinetobacter baumannii with different susceptibility to polymyxin revealed underlying resistance mechanism
by: Soo Sum eLean, et al.
Published: (2016-01-01)

Genetic Background of Carbapenem Resistant Acinetobacter baumannii in a Health Care Setting in Alexandria, Egypt
by: Amira Amine, et al.
Published: (2011-09-01)

Case Report: A case of spinal muscular atrophy with extensively drug-resistant Acinetobacter baumannii pneumonia treated with nebulization combined with intravenous polymyxin B: experience and a literature review
by: Bingqing Cao, et al.
Published: (2023-06-01)

Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant <i>Acinetobacter baumannii</i> with Polymyxin-Based Combinations
by: Marisol Wences, et al.
Published: (2022-07-01)

Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii-calcoaceticus Complex</i>
by: Rebeca Carvalho Lacerda Garcia, et al.
Published: (2023-08-01)

Acinetobacter Baumannii – Virulence Factors and Epidemiology of Infections
by: Marszalik Anna, et al.
Published: (2021-12-01)

Characterization of colistin-resistant A. baumannii isolated in Intensive Care Unit of an Italian Hospital
by: Erika Coppo, et al.
Published: (2013-03-01)

Impact of Polymyxin Resistance on Virulence and Fitness among Clinically Important Gram-Negative Bacteria
by: Yuan Wang, et al.
Published: (2022-06-01)

Colistin Resistance in <i>Acinetobacter baumannii:</i> Molecular Mechanisms and Epidemiology
by: Katarina Novović, et al.
Published: (2023-03-01)

Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study
by: Sijun Pan, et al.
Published: (2018-01-01)

An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1
by: Candace M. Marr, et al.
Published: (2020-10-01)